======= ANKRD1 ======= == Gene Information == * **Official Symbol**: ANKRD1 * **Official Name**: ankyrin repeat domain 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27063|27063]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15327|Q15327]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANKRD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANKRD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609599|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: May play an important role in endothelial cell activation. May act as a nuclear transcription factor that negatively regulates the expression of cardiac genes. Induction seems to be correlated with apoptotic cell death in hepatoma cells. {ECO:0000269|PubMed:15805281, ECO:0000269|PubMed:7730328}. |Ank 2| |Ank| |RNA polymerase II-specific DNA-binding transcription factor binding| |titin binding| |positive regulation of DNA damage response, signal transduction by p53 class mediator| |response to muscle stretch| |I band| |positive regulation of signal transduction by p53 class mediator| |R-SMAD binding| |regulation of DNA damage response, signal transduction by p53 class mediator| |negative regulation of DNA biosynthetic process| |sarcomere organization| |RNA polymerase II transcription factor binding| |myofibril assembly| |p53 binding| |cardiac muscle tissue morphogenesis| |cellular response to mechanical stimulus| |muscle tissue morphogenesis| |muscle organ morphogenesis| |positive regulation of response to DNA damage stimulus| |cellular component assembly involved in morphogenesis| |histone deacetylase binding| |regulation of DNA biosynthetic process| |actomyosin structure organization| |negative regulation of DNA metabolic process| |skeletal muscle tissue development| |skeletal muscle organ development| |fibrillar center| |striated muscle cell development| |muscle cell development| |cellular response to transforming growth factor beta stimulus| |response to transforming growth factor beta| |cardiac muscle tissue development| |cellular response to interleukin-1| |regulation of signal transduction by p53 class mediator| |cellular response to lipopolysaccharide| |cellular response to hypoxia| |cellular response to molecule of bacterial origin| |cellular response to decreased oxygen levels| |response to interleukin-1| |striated muscle cell differentiation| |response to mechanical stimulus| |cellular response to biotic stimulus| |cellular response to oxygen levels| |regulation of response to DNA damage stimulus| |cellular response to tumor necrosis factor| |transcription corepressor activity| |muscle cell differentiation| |heart morphogenesis| |response to tumor necrosis factor| |positive regulation of protein secretion| |positive regulation of neuron projection development| |transcription coactivator activity| |striated muscle tissue development| |positive regulation of peptide secretion| |muscle organ development| |muscle tissue development| |response to lipopolysaccharide| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |response to molecule of bacterial origin| |cellular response to external stimulus| |response to hypoxia| |regulation of DNA metabolic process| |response to decreased oxygen levels| |positive regulation of neuron differentiation| |response to oxygen levels| |positive regulation of cell projection organization| |regulation of lipid metabolic process| |positive regulation of secretion by cell| |positive regulation of protein transport| |positive regulation of secretion| |supramolecular fiber organization| |positive regulation of establishment of protein localization| |regulation of protein secretion| |positive regulation of neurogenesis| |muscle structure development| |actin cytoskeleton organization| |regulation of peptide secretion| |regulation of neuron projection development| |cellular response to growth factor stimulus| |cellular response to lipid| |heart development| |response to growth factor| |positive regulation of nervous system development| |cellular response to organic cyclic compound| |positive regulation of cell development| |tissue morphogenesis| |actin filament-based process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |regulation of neuron differentiation| |response to bacterium| |regulation of plasma membrane bounded cell projection organization| |positive regulation of cell death| |regulation of protein transport| |regulation of cell projection organization| |regulation of cellular response to stress| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |organelle assembly| |regulation of secretion| |regulation of neurogenesis| |cellular component morphogenesis| |response to lipid| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |response to organic cyclic compound| |regulation of nervous system development| |regulation of cell development| |animal organ morphogenesis| |positive regulation of cell differentiation| |positive regulation of transport| |cellular response to cytokine stimulus| |positive regulation of intracellular signal transduction| |regulation of protein localization| |cellular response to oxygen-containing compound| |response to cytokine| |cytoskeleton organization| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |generation of neurons| |regulation of apoptotic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |regulation of programmed cell death| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of signal transduction| |regulation of cell death| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.98| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17456 * **Expression level (log2 read counts)**: -2.28 {{:chemogenomics:nalm6 dist.png?nolink |}}